Skip to main content
Biomarkers and novel targets for metabolic disease leveraging branched-chain amino acid metabolism

Biomarkers and novel targets for metabolic disease leveraging branched-chain amino acid metabolism

Unmet Need 1 in 3 adults in the United States have a form of metabolic dysregulation, including diabetes, insulin resistance, obesity, non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). While these metabolic diseases range…

Read More

A method of screening and monitoring glycogen storage diseases with a single biomarker

A method of screening and monitoring glycogen storage diseases with a single biomarker

Unmet Need Glycogen storage disease type I (GSD I) is an autosomal recessive inherited disorder of carbohydrate metabolism associated with life threatening fasting hypoglycemia, and significant morbidity and mortality. Currently, the standard of care therapy…

Read More

A target for identifying and treating metabolic diseases including insulin resistance

A target for identifying and treating metabolic diseases including insulin resistance

Unmet Need The World Health Organization attributes over 70% of all deaths globally to noncommunicable diseases (NCD) including cardiovascular disease, diabetes, and cancer. Risk factors for NCDs include obesity, raised blood pressure, and the regional…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us